Unique funding strategy to leverage federal investment with matching commitments and flexibility to adjust to technical challenges
A seamless continuum of programs to advance promising HLBS-related technologies from validation to first-in-human trials
Milestone-driven project management and support to mitigate technical risk
Evaluation and oversight to adjust the program based on trends and challenges, and to share best practices
Catalyze was established by the National Heart, Lung, and Blood Institute (NHLBI) within the National Institutes of Health (NIH).